img

Global Amebiasis Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Amebiasis Drugs Market Research Report 2024

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.
According to Mr Accuracy reports new survey, global Amebiasis Drugs market is projected to reach US$ 1323.9 million in 2029, increasing from US$ 875 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Amebiasis Drugs market research.
The amebiasis drugs market is driven by the high burden of amebiasis infections, caused by the parasite Entamoeba histolytica, especially in developing regions with poor sanitation and healthcare facilities. Amebiasis can lead to severe gastrointestinal symptoms and potentially life-threatening complications. The increasing prevalence and severity of the disease have contributed to the demand for effective drugs to treat and manage amebiasis. Additionally, advancements in medical research and drug development have led to the introduction of new and improved therapies for better patient outcomes. However, challenges include the need for early diagnosis and proper management to prevent complications, potential drug resistance, and limited access to healthcare in some regions. Overcoming these challenges through increased awareness, affordable treatment options, and improved healthcare infrastructure will be crucial for the sustained growth of the amebiasis drugs market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Amebiasis Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Dr. Reddy’s Laboratories
Mission Pharmacal
Aceto Corporation
Mylan Pharmaceuticals
Impax Laboratories
Pfizer
Sanofi
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Sun Pharmaceutical
Heritage Pharmaceuticals
Segment by Type
Metronidazole
Paromomycin
Tinidazole
Other

Segment by Application


Hospital
Pharmacy

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Amebiasis Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Amebiasis Drugs Market Overview
1.1 Product Overview and Scope of Amebiasis Drugs
1.2 Amebiasis Drugs Segment by Type
1.2.1 Global Amebiasis Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Metronidazole
1.2.3 Paromomycin
1.2.4 Tinidazole
1.2.5 Other
1.3 Amebiasis Drugs Segment by Application
1.3.1 Global Amebiasis Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Amebiasis Drugs Market Size Estimates and Forecasts
1.4.1 Global Amebiasis Drugs Revenue 2018-2029
1.4.2 Global Amebiasis Drugs Sales 2018-2029
1.4.3 Global Amebiasis Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Amebiasis Drugs Market Competition by Manufacturers
2.1 Global Amebiasis Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Amebiasis Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Amebiasis Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Amebiasis Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Amebiasis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amebiasis Drugs, Product Type & Application
2.7 Amebiasis Drugs Market Competitive Situation and Trends
2.7.1 Amebiasis Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amebiasis Drugs Players Market Share by Revenue
2.7.3 Global Amebiasis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amebiasis Drugs Retrospective Market Scenario by Region
3.1 Global Amebiasis Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Amebiasis Drugs Global Amebiasis Drugs Sales by Region: 2018-2029
3.2.1 Global Amebiasis Drugs Sales by Region: 2018-2024
3.2.2 Global Amebiasis Drugs Sales by Region: 2024-2029
3.3 Global Amebiasis Drugs Global Amebiasis Drugs Revenue by Region: 2018-2029
3.3.1 Global Amebiasis Drugs Revenue by Region: 2018-2024
3.3.2 Global Amebiasis Drugs Revenue by Region: 2024-2029
3.4 North America Amebiasis Drugs Market Facts & Figures by Country
3.4.1 North America Amebiasis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Amebiasis Drugs Sales by Country (2018-2029)
3.4.3 North America Amebiasis Drugs Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amebiasis Drugs Market Facts & Figures by Country
3.5.1 Europe Amebiasis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Amebiasis Drugs Sales by Country (2018-2029)
3.5.3 Europe Amebiasis Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amebiasis Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Amebiasis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Amebiasis Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Amebiasis Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amebiasis Drugs Market Facts & Figures by Country
3.7.1 Latin America Amebiasis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Amebiasis Drugs Sales by Country (2018-2029)
3.7.3 Latin America Amebiasis Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amebiasis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Amebiasis Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Amebiasis Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Amebiasis Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Amebiasis Drugs Sales by Type (2018-2029)
4.1.1 Global Amebiasis Drugs Sales by Type (2018-2024)
4.1.2 Global Amebiasis Drugs Sales by Type (2024-2029)
4.1.3 Global Amebiasis Drugs Sales Market Share by Type (2018-2029)
4.2 Global Amebiasis Drugs Revenue by Type (2018-2029)
4.2.1 Global Amebiasis Drugs Revenue by Type (2018-2024)
4.2.2 Global Amebiasis Drugs Revenue by Type (2024-2029)
4.2.3 Global Amebiasis Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Amebiasis Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Amebiasis Drugs Sales by Application (2018-2029)
5.1.1 Global Amebiasis Drugs Sales by Application (2018-2024)
5.1.2 Global Amebiasis Drugs Sales by Application (2024-2029)
5.1.3 Global Amebiasis Drugs Sales Market Share by Application (2018-2029)
5.2 Global Amebiasis Drugs Revenue by Application (2018-2029)
5.2.1 Global Amebiasis Drugs Revenue by Application (2018-2024)
5.2.2 Global Amebiasis Drugs Revenue by Application (2024-2029)
5.2.3 Global Amebiasis Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Amebiasis Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Dr. Reddy’s Laboratories
6.1.1 Dr. Reddy’s Laboratories Corporation Information
6.1.2 Dr. Reddy’s Laboratories Description and Business Overview
6.1.3 Dr. Reddy’s Laboratories Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Dr. Reddy’s Laboratories Amebiasis Drugs Product Portfolio
6.1.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.2 Mission Pharmacal
6.2.1 Mission Pharmacal Corporation Information
6.2.2 Mission Pharmacal Description and Business Overview
6.2.3 Mission Pharmacal Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Mission Pharmacal Amebiasis Drugs Product Portfolio
6.2.5 Mission Pharmacal Recent Developments/Updates
6.3 Aceto Corporation
6.3.1 Aceto Corporation Corporation Information
6.3.2 Aceto Corporation Description and Business Overview
6.3.3 Aceto Corporation Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Aceto Corporation Amebiasis Drugs Product Portfolio
6.3.5 Aceto Corporation Recent Developments/Updates
6.4 Mylan Pharmaceuticals
6.4.1 Mylan Pharmaceuticals Corporation Information
6.4.2 Mylan Pharmaceuticals Description and Business Overview
6.4.3 Mylan Pharmaceuticals Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Mylan Pharmaceuticals Amebiasis Drugs Product Portfolio
6.4.5 Mylan Pharmaceuticals Recent Developments/Updates
6.5 Impax Laboratories
6.5.1 Impax Laboratories Corporation Information
6.5.2 Impax Laboratories Description and Business Overview
6.5.3 Impax Laboratories Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Impax Laboratories Amebiasis Drugs Product Portfolio
6.5.5 Impax Laboratories Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Pfizer Amebiasis Drugs Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sanofi Amebiasis Drugs Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Lupin Pharmaceuticals
6.8.1 Lupin Pharmaceuticals Corporation Information
6.8.2 Lupin Pharmaceuticals Description and Business Overview
6.8.3 Lupin Pharmaceuticals Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Lupin Pharmaceuticals Amebiasis Drugs Product Portfolio
6.8.5 Lupin Pharmaceuticals Recent Developments/Updates
6.9 Glenmark Pharmaceuticals
6.9.1 Glenmark Pharmaceuticals Corporation Information
6.9.2 Glenmark Pharmaceuticals Description and Business Overview
6.9.3 Glenmark Pharmaceuticals Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Glenmark Pharmaceuticals Amebiasis Drugs Product Portfolio
6.9.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.10 Sun Pharmaceutical
6.10.1 Sun Pharmaceutical Corporation Information
6.10.2 Sun Pharmaceutical Description and Business Overview
6.10.3 Sun Pharmaceutical Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Sun Pharmaceutical Amebiasis Drugs Product Portfolio
6.10.5 Sun Pharmaceutical Recent Developments/Updates
6.11 Heritage Pharmaceuticals
6.11.1 Heritage Pharmaceuticals Corporation Information
6.11.2 Heritage Pharmaceuticals Amebiasis Drugs Description and Business Overview
6.11.3 Heritage Pharmaceuticals Amebiasis Drugs Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Heritage Pharmaceuticals Amebiasis Drugs Product Portfolio
6.11.5 Heritage Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amebiasis Drugs Industry Chain Analysis
7.2 Amebiasis Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amebiasis Drugs Production Mode & Process
7.4 Amebiasis Drugs Sales and Marketing
7.4.1 Amebiasis Drugs Sales Channels
7.4.2 Amebiasis Drugs Distributors
7.5 Amebiasis Drugs Customers
8 Amebiasis Drugs Market Dynamics
8.1 Amebiasis Drugs Industry Trends
8.2 Amebiasis Drugs Market Drivers
8.3 Amebiasis Drugs Market Challenges
8.4 Amebiasis Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Amebiasis Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Amebiasis Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Amebiasis Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Amebiasis Drugs Sales (K Unit) of Key Manufacturers (2018-2024)
Table 5. Global Amebiasis Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Amebiasis Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Amebiasis Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Amebiasis Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Amebiasis Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Amebiasis Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amebiasis Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Amebiasis Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amebiasis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amebiasis Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Amebiasis Drugs Sales by Region (2018-2024) & (K Unit)
Table 18. Global Amebiasis Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Amebiasis Drugs Sales by Region (2024-2029) & (K Unit)
Table 20. Global Amebiasis Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Amebiasis Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Amebiasis Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Amebiasis Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Amebiasis Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Amebiasis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Amebiasis Drugs Sales by Country (2018-2024) & (K Unit)
Table 27. North America Amebiasis Drugs Sales by Country (2024-2029) & (K Unit)
Table 28. North America Amebiasis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Amebiasis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Amebiasis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Amebiasis Drugs Sales by Country (2018-2024) & (K Unit)
Table 32. Europe Amebiasis Drugs Sales by Country (2024-2029) & (K Unit)
Table 33. Europe Amebiasis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Amebiasis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Amebiasis Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Amebiasis Drugs Sales by Region (2018-2024) & (K Unit)
Table 37. Asia Pacific Amebiasis Drugs Sales by Region (2024-2029) & (K Unit)
Table 38. Asia Pacific Amebiasis Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Amebiasis Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Amebiasis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Amebiasis Drugs Sales by Country (2018-2024) & (K Unit)
Table 42. Latin America Amebiasis Drugs Sales by Country (2024-2029) & (K Unit)
Table 43. Latin America Amebiasis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Amebiasis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Amebiasis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Amebiasis Drugs Sales by Country (2018-2024) & (K Unit)
Table 47. Middle East & Africa Amebiasis Drugs Sales by Country (2024-2029) & (K Unit)
Table 48. Middle East & Africa Amebiasis Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Amebiasis Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Amebiasis Drugs Sales (K Unit) by Type (2018-2024)
Table 51. Global Amebiasis Drugs Sales (K Unit) by Type (2024-2029)
Table 52. Global Amebiasis Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Amebiasis Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Amebiasis Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Amebiasis Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Amebiasis Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Amebiasis Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Amebiasis Drugs Price (USD/Unit) by Type (2018-2024)
Table 59. Global Amebiasis Drugs Price (USD/Unit) by Type (2024-2029)
Table 60. Global Amebiasis Drugs Sales (K Unit) by Application (2018-2024)
Table 61. Global Amebiasis Drugs Sales (K Unit) by Application (2024-2029)
Table 62. Global Amebiasis Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Amebiasis Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Amebiasis Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Amebiasis Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Amebiasis Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Amebiasis Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Amebiasis Drugs Price (USD/Unit) by Application (2018-2024)
Table 69. Global Amebiasis Drugs Price (USD/Unit) by Application (2024-2029)
Table 70. Dr. Reddy’s Laboratories Corporation Information
Table 71. Dr. Reddy’s Laboratories Description and Business Overview
Table 72. Dr. Reddy’s Laboratories Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Dr. Reddy’s Laboratories Amebiasis Drugs Product
Table 74. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 75. Mission Pharmacal Corporation Information
Table 76. Mission Pharmacal Description and Business Overview
Table 77. Mission Pharmacal Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Mission Pharmacal Amebiasis Drugs Product
Table 79. Mission Pharmacal Recent Developments/Updates
Table 80. Aceto Corporation Corporation Information
Table 81. Aceto Corporation Description and Business Overview
Table 82. Aceto Corporation Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Aceto Corporation Amebiasis Drugs Product
Table 84. Aceto Corporation Recent Developments/Updates
Table 85. Mylan Pharmaceuticals Corporation Information
Table 86. Mylan Pharmaceuticals Description and Business Overview
Table 87. Mylan Pharmaceuticals Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Mylan Pharmaceuticals Amebiasis Drugs Product
Table 89. Mylan Pharmaceuticals Recent Developments/Updates
Table 90. Impax Laboratories Corporation Information
Table 91. Impax Laboratories Description and Business Overview
Table 92. Impax Laboratories Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Impax Laboratories Amebiasis Drugs Product
Table 94. Impax Laboratories Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Pfizer Amebiasis Drugs Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Sanofi Amebiasis Drugs Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Lupin Pharmaceuticals Corporation Information
Table 106. Lupin Pharmaceuticals Description and Business Overview
Table 107. Lupin Pharmaceuticals Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Lupin Pharmaceuticals Amebiasis Drugs Product
Table 109. Lupin Pharmaceuticals Recent Developments/Updates
Table 110. Glenmark Pharmaceuticals Corporation Information
Table 111. Glenmark Pharmaceuticals Description and Business Overview
Table 112. Glenmark Pharmaceuticals Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Glenmark Pharmaceuticals Amebiasis Drugs Product
Table 114. Glenmark Pharmaceuticals Recent Developments/Updates
Table 115. Sun Pharmaceutical Corporation Information
Table 116. Sun Pharmaceutical Description and Business Overview
Table 117. Sun Pharmaceutical Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Sun Pharmaceutical Amebiasis Drugs Product
Table 119. Sun Pharmaceutical Recent Developments/Updates
Table 120. Heritage Pharmaceuticals Corporation Information
Table 121. Heritage Pharmaceuticals Description and Business Overview
Table 122. Heritage Pharmaceuticals Amebiasis Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Heritage Pharmaceuticals Amebiasis Drugs Product
Table 124. Heritage Pharmaceuticals Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Amebiasis Drugs Distributors List
Table 128. Amebiasis Drugs Customers List
Table 129. Amebiasis Drugs Market Trends
Table 130. Amebiasis Drugs Market Drivers
Table 131. Amebiasis Drugs Market Challenges
Table 132. Amebiasis Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amebiasis Drugs
Figure 2. Global Amebiasis Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Amebiasis Drugs Market Share by Type in 2022 & 2029
Figure 4. Metronidazole Product Picture
Figure 5. Paromomycin Product Picture
Figure 6. Tinidazole Product Picture
Figure 7. Other Product Picture
Figure 8. Global Amebiasis Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Amebiasis Drugs Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Pharmacy
Figure 12. Global Amebiasis Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Amebiasis Drugs Market Size (2018-2029) & (US$ Million)
Figure 14. Global Amebiasis Drugs Sales (2018-2029) & (K Unit)
Figure 15. Global Amebiasis Drugs Average Price (USD/Unit) & (2018-2029)
Figure 16. Amebiasis Drugs Report Years Considered
Figure 17. Amebiasis Drugs Sales Share by Manufacturers in 2022
Figure 18. Global Amebiasis Drugs Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Amebiasis Drugs Players: Market Share by Revenue in 2022
Figure 20. Amebiasis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Amebiasis Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Amebiasis Drugs Sales Market Share by Country (2018-2029)
Figure 23. North America Amebiasis Drugs Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Amebiasis Drugs Sales Market Share by Country (2018-2029)
Figure 27. Europe Amebiasis Drugs Revenue Market Share by Country (2018-2029)
Figure 28. Germany Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Amebiasis Drugs Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Amebiasis Drugs Revenue Market Share by Region (2018-2029)
Figure 35. China Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Amebiasis Drugs Sales Market Share by Country (2018-2029)
Figure 46. Latin America Amebiasis Drugs Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Amebiasis Drugs Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Amebiasis Drugs Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Amebiasis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Amebiasis Drugs by Type (2018-2029)
Figure 56. Global Revenue Market Share of Amebiasis Drugs by Type (2018-2029)
Figure 57. Global Amebiasis Drugs Price (USD/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Amebiasis Drugs by Application (2018-2029)
Figure 59. Global Revenue Market Share of Amebiasis Drugs by Application (2018-2029)
Figure 60. Global Amebiasis Drugs Price (USD/Unit) by Application (2018-2029)
Figure 61. Amebiasis Drugs Value Chain
Figure 62. Amebiasis Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed